XML 27 R7.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Changes in Equity - USD ($)
$ in Millions
Total
Common stock
Retained earnings
Derivative Hedging Instrument
AOCI
Non-controlling interests
Beginning balance (in shares) at Dec. 31, 2017   142,094,275        
Beginning balance at Dec. 31, 2017 $ 3,860.4 $ 2,734.8 $ 1,173.3   $ 0.0 $ (47.7)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 62.9   60.5     2.4
Issuance of stock for compensation and reinvested dividends (in shares)   138,828        
Issuance of stock for compensation and reinvested dividends (3.7) $ (3.7)        
Dividends declared on common stock (57.7)   (57.7)      
Stock compensation expense 2.5 $ 2.5        
Net current period other comprehensive income 0.0          
Ending balance (in shares) at Mar. 31, 2018   142,233,103        
Ending balance at Mar. 31, 2018 3,864.4 $ 2,733.6 1,176.1   0.0 (45.3)
Beginning balance (in shares) at Dec. 31, 2018   255,326,252        
Beginning balance at Dec. 31, 2018 9,990.7 $ 8,685.2 1,346.0   (3.0) (37.5)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 103.4   99.5     3.9
Issuance of stock for compensation and reinvested dividends (in shares)   60,594        
Issuance of stock for compensation and reinvested dividends (1.6) $ (1.6)        
Dividends declared on common stock (119.8)   (119.8)      
Stock compensation expense 5.4 $ 5.4        
Repurchase of common stock (in shares)   (10,548,060)        
Repurchase of common stock under repurchase plan (578.3) $ (578.3)        
Consolidation of noncontrolling interests 3.8         3.8
Distributions to shareholders of noncontrolling interests (1.4)         (1.4)
Net current period other comprehensive income (10.2)     $ (10.2)    
Other (0.3) $ (0.3)        
Ending balance (in shares) at Mar. 31, 2019   244,838,786        
Ending balance at Mar. 31, 2019 $ 9,391.7 $ 8,110.4 $ 1,325.7   $ (13.2) $ (31.2)